Medical Economics December 3, 2020
We’re at the point today where more people investment is needed to evaluate how, when, and where to best use the technology
It’s been said that Covid-19 telescoped the deployment of telehealth technology that might have taken years into weeks, and that is true. The administration waived regulations that had served to raise the cost of the technology, and increased reimbursement to parity with in-office visits, addressing two key obstacles that had constrained its adoption.
By some happy coincidence, telehealth technology and our digital infrastructure had matured to the point that it could support far broader use just when it was needed. Multiple available technology products were reasonably user-friendly and generally affordable, and the need was there given that...